John G. Page

2.1k total citations
43 papers, 1.7k citations indexed

About

John G. Page is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, John G. Page has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmacology. Recurrent topics in John G. Page's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). John G. Page is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). John G. Page collaborates with scholars based in United States. John G. Page's co-authors include Elliot S. Vesell, G. Thomas Passananti, G. Dirnberger, Joseph E. Tomaszewski, Peter A. Lee, Adaline C. Smith, Lindsay M. Arnold, Karen Schweikart, David Eisner and Mark B. Cannell and has published in prestigious journals such as Science, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

John G. Page

42 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John G. Page United States 21 532 481 234 234 175 43 1.7k
E. Mussini Italy 21 398 0.7× 204 0.4× 122 0.5× 150 0.6× 92 0.5× 113 1.8k
Véronique Descatoire France 31 686 1.3× 1.2k 2.6× 141 0.6× 614 2.6× 149 0.9× 56 2.8k
Koiçhi Yokogawa Japan 23 626 1.2× 254 0.5× 318 1.4× 580 2.5× 114 0.7× 80 2.0k
Jan Hendrickx Belgium 29 1.1k 2.0× 607 1.3× 234 1.0× 428 1.8× 78 0.4× 79 3.0k
Rafael Bruck Israel 31 631 1.2× 448 0.9× 91 0.4× 350 1.5× 37 0.2× 73 2.5k
H Orrego Canada 26 297 0.6× 252 0.5× 69 0.3× 81 0.3× 77 0.4× 60 2.2k
D N Baron United Kingdom 19 302 0.6× 113 0.2× 117 0.5× 186 0.8× 161 0.9× 73 1.4k
Yuji Moriwaki Japan 27 758 1.4× 161 0.3× 85 0.4× 93 0.4× 216 1.2× 112 2.3k
J. Paul Phillips United States 17 313 0.6× 201 0.4× 92 0.4× 145 0.6× 30 0.2× 30 1.4k
Kenichi Kitani Japan 26 627 1.2× 213 0.4× 110 0.5× 441 1.9× 63 0.4× 115 2.3k

Countries citing papers authored by John G. Page

Since Specialization
Citations

This map shows the geographic impact of John G. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Page more than expected).

Fields of papers citing papers by John G. Page

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Page. The network helps show where John G. Page may publish in the future.

Co-authorship network of co-authors of John G. Page

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Page. A scholar is included among the top collaborators of John G. Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Page. John G. Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, John G., et al.. (2024). Loss of Slc35a2 alters development of the mouse cerebral cortex. Neuroscience Letters. 836. 137881–137881. 10 indexed citations
2.
3.
4.
Page, John G., Karen Schweikart, Joseph E. Tomaszewski, et al.. (2007). Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer. American Journal of Obstetrics and Gynecology. 196(4). 389.e1–389.e10. 31 indexed citations
5.
Jia, Lee, Karen Schweikart, Joseph E. Tomaszewski, et al.. (2007). Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption. Food and Chemical Toxicology. 46(1). 203–211. 79 indexed citations
6.
Papadopoulou, Maria V., et al.. (2004). IND-directed, five-day repeat dose toxicity study of NLCQ-1 (NSC 709257) administered with or without Taxol® in Sprague Dawley rats.. Cancer Research. 64. 485–485. 1 indexed citations
7.
Kurokawa, Katsumi, Yun Zhang, Charles Hébert, et al.. (2004). Sensory nerve conduction of the plantar nerve compared with other nerve conduction tests in rats. Clinical Neurophysiology. 115(7). 1677–1682. 20 indexed citations
8.
Waterhouse, Rikki N., Michael G. Stabin, & John G. Page. (2003). Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [18F]FPS. Nuclear Medicine and Biology. 30(5). 555–563. 22 indexed citations
9.
Farnell, Daniel R., Paula W. Allan, Donald L. Hill, et al.. (1997). Toxicity of Cordycepin in Combination with the Adenosine Deaminase Inhibitor 2′-Deoxycoformycin in Beagle Dogs. Toxicology and Applied Pharmacology. 147(1). 39–45. 39 indexed citations
10.
Erickson‐Miller, Connie L., Richard May, Joseph E. Tomaszewski, et al.. (1997). Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemotherapy and Pharmacology. 39(5). 467–472. 82 indexed citations
11.
O’Callaghan, James P., et al.. (1996). Acute and Chronic Administration of Ibogaine to the Rat Results in Astrogliosis That Is Not Confined to the Cerebellar Vermisae. Annals of the New York Academy of Sciences. 801(1). 205–216. 10 indexed citations
12.
Trang, J M, et al.. (1993). Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.. Drug Metabolism and Disposition. 21(1). 189–193. 8 indexed citations
13.
Sanders, Steven W., et al.. (1992). The effects of lansoprazole, a new H+,K+‐ATPase inhibitor, on gastric pH and serum gastrin. Alimentary Pharmacology & Therapeutics. 6(3). 359–372. 49 indexed citations
14.
Conley, Barbara A., et al.. (1991). The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide. Cancer Chemotherapy and Pharmacology. 28(1). 33–38. 5 indexed citations
15.
Wientjes, M. Guillaume, Michael E. Placke, Ming Chang, et al.. (1991). Pharmacokinetics of 2′,3′-dideoxyadenosine in dogs. Investigational New Drugs. 9(2). 159–168. 9 indexed citations
16.
Lee, Peter A. & John G. Page. (1989). Effects of leuprolide in the treatment of central precocious puberty. The Journal of Pediatrics. 114(2). 321–324. 50 indexed citations
17.
Smith, Adaline C., et al.. (1989). Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.. PubMed. 49(19). 5385–91. 25 indexed citations
18.
Page, John G.. (1970). The Effect of Desmethylimipramine and Theophylline on Plasma Free Fatty Acids and Blood Glucose in Rats. Pharmacology. 3(1). 6–14. 3 indexed citations
19.
Vesell, Elliot S. & John G. Page. (1968). Genetic Control of Drug Levels in Man: Antipyrine. Science. 161(3836). 72–73. 175 indexed citations
20.
Finger, Kenneth F. & John G. Page. (1966). Antagonism of Free Fatty Acid Release from Rat Epididymal Fat Tissue by Desmethylimipramine. Journal of Pharmaceutical Sciences. 55(10). 1025–1027. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Mussini Breakdown of academic impact, for papers by Véronique Descatoire Breakdown of academic impact, for papers by Koiçhi Yokogawa Breakdown of academic impact, for papers by Jan Hendrickx Breakdown of academic impact, for papers by Rafael Bruck Breakdown of academic impact, for papers by H Orrego Breakdown of academic impact, for papers by D N Baron Breakdown of academic impact, for papers by Yuji Moriwaki Breakdown of academic impact, for papers by J. Paul Phillips Breakdown of academic impact, for papers by Kenichi Kitani
Rankless by CCL
2026